Sunday, February 22, 2026 1:55:09 PM
If you don't like his theory, that's fine. He lays it out and everyone can decide for themselves.
The constant labeling people as pumpers and fuddsters contributes nothing but noise to the board.
I will point out that there seems to be a few posters that are constantly attacking other posters rather than the contents of their posts or discussing the company.
Again, each reader can come to his own conclusions as to what that is about.
As for the economics of paying posters, that is an interesting question. One has to ask the question of who would benefit from such a strategy. To answer that question one has to figure out who has a vested interest in manipulating the share price and how effective that process would be, i.e. how much bang for the buck can be realized. None of these questions have clear answers and that is be design of the participants involved.
My observation is that the share price is more easily manipulated down than up, for whatever that is worth.
Posters have many different takes on the current situation. The reasons for that vary from lack of information, to considering all the possible outcomes for the future. Discussing a range of positive outcomes is not more pumping than discussing the range of negative outcomes is fudding.
Constantly attempting to discredit other posters that have a different view of the situation by personal attacks is a tell in my view.
What it is a tell of, is up to each reader to decide.
The constant labeling people as pumpers and fuddsters contributes nothing but noise to the board.
I will point out that there seems to be a few posters that are constantly attacking other posters rather than the contents of their posts or discussing the company.
Again, each reader can come to his own conclusions as to what that is about.
As for the economics of paying posters, that is an interesting question. One has to ask the question of who would benefit from such a strategy. To answer that question one has to figure out who has a vested interest in manipulating the share price and how effective that process would be, i.e. how much bang for the buck can be realized. None of these questions have clear answers and that is be design of the participants involved.
My observation is that the share price is more easily manipulated down than up, for whatever that is worth.
Posters have many different takes on the current situation. The reasons for that vary from lack of information, to considering all the possible outcomes for the future. Discussing a range of positive outcomes is not more pumping than discussing the range of negative outcomes is fudding.
Constantly attempting to discredit other posters that have a different view of the situation by personal attacks is a tell in my view.
What it is a tell of, is up to each reader to decide.
Success is the best revenge.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
